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Objectives. This study was designed to ascertain whether car-
diodepressive mediators released after ischemia originate from
coronary endothelial cells.
Background. Endothelial cells modulate myocardial contractil-
ity under physiologic conditions. Few data are available describ-
ing the role of coronary endothelial cells on myocardial function
after ischemia.
Methods. Using a model of sequential perfusion of two isolated
rat hearts, the effect of the reoxygenated coronary effluent of heart
I was investigated on myocardial contractility of heart II. After
40 min of separate perfusion at constant flow (10 ml/min), the two
hearts were perfused sequentially with (group I) or without
(control group) preceding ischemia (10 min) of heart I. In groups
II and III, the coronary endothelium of heart I was functionally
removed by Triton X-100 or hyperkalemic infusion before global
ischemia. Endothelial damage was confirmed by functional tests
and electron microscopy.
Results. Under control conditions no changes were observed in
heart II during sequential perfusion. In contrast, after 10 min of
ischemia in heart I, a marked reversible decrease in left ventric-
ular pressure, left ventricular dP/dtmax and left ventricular
dP/dtmin (255%, 266% and 270%, respectively) was observed in
heart II. Heart rate and coronary perfusion pressure did not
change significantly. Selective endothelial damage of heart I
before ischemia did not modify the negative inotropic effect
observed in heart II.
Conclusions. Cardiodepressive mediators are released after
ischemia during reperfusion from an isolated heart and induce a
reversible negative inotropic effect in a sequentially perfused
heart. It is unlikely that these agents are derived from the
coronary endothelium.
(J Am Coll Cardiol 1997;29:1390–6)
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Both clinical and experimental studies have shown that reper-
fusion after myocardial ischemia produces direct injury and
triggers the release of various mediators, including leukocyte-
derived oxygen free radicals, arachidonic acid, cytokines and
cytotoxic enzymes (1–5).
Recently, we have shown that after global ischemia in an
isolated heart, cardiodepressive mediators are released during
reperfusion from myocardial tissue, and these mediators then
induce a rapid decrease in contractility of a sequentially
perfused nonischemic second heart (6). The second heart was
used as a bioassay to further characterize the effects of these
mediators. However, no conclusion could be drawn from these
data on the cellular source of the involved mediators.
Numerous studies have shown that myocardial contractility
is modulated by coronary and endocardial endothelial cells
(7–18). The underlying mechanisms are still under investiga-
tion. Besides currently accepted mediators released from en-
dothelial cells, such as endothelin (19–22), nitric oxide (23–26)
and prostacyclin (18), other unidentified cardioactive sub-
stances upregulating or downregulating myocardial contractil-
ity are discussed (13). Furthermore, endothelial cells may
contribute to cardiac malfunction during ischemia and reper-
fusion. Interestingly, endothelial cells incubated under hypoxic
conditions release mediators that induce a pronounced de-
crease in contractility in superfused isolated myocytes (27).
The purpose of the study was to ascertain in a double-heart
model the role of coronary endothelial cells in modulating
myocardial contractile function after ischemia. After a global
stop flow–ischemia of 10 min reperfusion was performed in
isolated hearts, and the effects of the coronary effluent on
contractile function were characterized in sequentially per-
fused hearts. To verify whether the vascular endothelial cells
are the source of mediators released during reperfusion, the
coronary endothelial cells of the first heart were damaged by
two different techniques.
Methods
Perfusion of two isolated rat hearts—“double-heart model”
(Fig. 1). Rats (Charles River, Germany) of either gender
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weighing 200 to 300 g were killed mechanically. The hearts
were excised and perfused separately according to the Langen-
dorff technique at a constant flow rate of 10 ml/min with a
modified Krebs-Henseleit solution (in mmol/liter—NaCl
127.1, KCl 4.7, MgSO4 1.1, KH2PO4 1.19, NaHCO3 24.9,
CaCl2 1.26, glucose 8.93, HEPES 10), equilibrated with 95%
oxygen and 5% carbon dioxide at 37°C, pH 7.4. Left and right
ventricular pressures were recorded by means of a fluid-filled
latex balloon inserted through the mitral and tricuspid valves
and attached to a pressure transducer (Spectramed, Germany)
and chart recorder. The left ventricular end-diastolic pressure
was maintained at 5 mm Hg. The balloon pressure was
electronically differentiated to yield the rate of intraventricular
pressure development (dP/dt) and heart rate. Coronary flow
rates were monitored with an ultrasound flowmeter (Trans-
sonic) connected to a flow probe, which was inserted into the
aortic arch. Coronary perfusion pressure was monitored with a
pressure transducer attached to the aortic perfusion cannula.
All variables were continuously displayed. Continuous regis-
tration included heart rate, left ventricular pressure (LVP), left
ventricular end-diastolic pressure, left ventricular peak positive
dP/dt (LVdP/dtmax), left ventricular peak negative dP/dt
(LVdP/dtmin), right ventricular pressure (RVP), right ventric-
ular peak positive dP/dt (RVdP/dtmax), right ventricular peak
negative dP/dt (RVdP/dtmin), coronary flow rates and coronary
perfusion pressure.
After an equilibration period at separate perfusion, the two
hearts were sequentially perfused according to the technique
described by Schrader and Bardenheuer (28). The coronary
effluent of the first heart was reoxygenated in a microchamber
and transported to the second heart by a roller pump. The
coronary flow rates of the second heart were adjusted to the
flow rates of the first heart by means of electronic processing.
This was established by a photodiode incorporated into the
microchamber controlling the speed of the pump. Reoxygen-
ation and the transit time of the coronary effluent from the first
to the second heart had been reduced (,3 s) by miniaturiza-
tion of the oxygenator (,500 ml) and the connecting tubes
(inner diameter 0.5 mm). With a system of valves and pumps,
it was possible to achieve different perfusion modes: separate
perfusion at constant pressure, separate perfusion at constant
flow and sequential perfusion (Fig. 1).
Ethics. All animals received humane care, as described in
“Principles of Laboratory Animal Care,” formulated by the
National Society for Medical Research, and the “Guide for
the Care and Use of Laboratory Animals,” prepared by the
National Academy of Sciences and published by the National
Institutes of Health (NIH publication no. 80-23, revised 1985).
Methods for damaging endothelial cells. Two different
methods were applied to damage endothelial cells. In some
experiments, the coronary endothelium was selectively de-
stroyed by a 10-s intracoronary infusion of Triton X-100
dissolved in a Krebs-Henseleit solution at a dilution of 1:200.
The infusion rate of Triton X-100 was 1% of the coronary flow
rate. After this procedure, the hearts were allowed to re-
equilibrate for 20 min. The amount of Triton X-100 necessary
to damage the coronary endothelium was established after
several pilot experiments. Endothelial damage was confirmed
with electron microscopy. In addition, the effectiveness of
Triton X-100 to also abolish the physiologic function of the
coronary vascular endothelium was verified by endothelial-
dependent and -independent vasodilation before and after
Triton X-100 infusion. The second procedure to damage
coronary endothelial cells has been described in detail by
Griffith et al. (29) and Ramaciotti et al. (13). After equilibra-
tion, the perfusion of the hearts was switched to a high
potassium Krebs-Henseleit solution (replacing 40 mmol/liter
of NaCl with 40 mmol/liter of KCl) infused over 10 min. Within
15 s of initiating the high potassium perfusion, the hearts
went into contracture and mean perfusion pressure rose to
200 mm Hg. This procedure has been reported to damage
coronary endothelial cells of the arterioles and to eliminate the
Abbreviations and Acronyms
5-HT 5 5-hydroxytryptamine
DMPX 5 3,7-dimethyl-1-propargylxanthine
DPCPX 5 1,3-dipropyl-8-cyclopentylxanthine
dP/dt 5 rate of intraventricular pressure
development
GTN 5 glyceryl trinitrate
LVdP/dtmax (LVdP/dtmin) 5 left ventricular peak positive
(negative) dP/dt
LVP 5 left ventricular pressure
RVdP/dtmax (RVdP/dtmin) 5 right ventricular peak positive
(negative) dP/dt
RVP 5 right ventricular pressure
Figure 1. Schematic illustration of the double-heart model. Separate
perfusion at constant pressure is performed by opening V1 and V2.
After closure of V1 and V2 the perfusion mode is switched to
perfusion at constant flow by means of P1 and P2. Serial perfusion is
realized by closure of P2 and opening of V3, while the coronary
effluent of heart I is collected and reoxygenized in the microchamber
and then transported to heart II by P3. The coronary flow rates of heart
II are adjusted to those of heart I by means of electronic processing.
K-H 5 Krebs-Henseleit; P 5 roller pump; V 5 valve.
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decrease in coronary resistance produced by cholinergic drugs
(29). Capillaries and venules were not damaged and main-
tained a normal appearance. Furthermore, transmission elec-
tron microscopic studies have confirmed that no normal endo-
thelial cells remained within the arterial vasculature (13,29). At
the end of hyperkalemic perfusion, the hearts were again
perfused with normal Krebs-Henseleit solution and contractile
function was reestablished within 5 min.
Functional investigation of the vascular integrity and con-
tractile function before and after selective endothelial damage.
The coronary response to the endothelial-independent vasodi-
lators glyceryl trinitrate (GTN, 1 mmol/liter, n 5 3) and
papaverine (5 mmol/liter, n 5 4) and to the endothelial-
dependent vasodilators 5-hydroxytryptamine (5-HT, 1 mmol/
liter, n 5 4) and bradykinin (1 mmol/liter, n 5 3) was
investigated under basal conditions by means of intracoronary
infusion in isolated rat hearts while being perfused at constant
pressure (80 cm H2O). The perfusion mode was then switched
to perfusion at a constant flow rate of 10 ml/min, and Triton
X-100 was intracoronarily infused as described earlier. At the
end of the recovery period after administration of Triton
X-100, the perfusion mode was switched once more to perfu-
sion at constant pressure and the effects of the endothelial-
dependent and -independent vasodilators were examined.
In additional series of experiments, the contractile response
of the isolated hearts to the beta-receptor agonist isoprotere-
nol (5 nmol/liter, n 5 4) was investigated before and after
infusion of Triton-X 100.
Experimental protocol. The hearts were perfused at a
constant flow rate of 10 ml/min for 40 min. This was followed
by sequential perfusion with (group I) or without (control
group) preceding stop flow–ischemia (10 min) of the first
heart, as described in Figure 2. In groups II and III, the
coronary endothelium of the first heart was damaged before
initiating global ischemia by Triton X-100 infusion or by
hyperkalemic perfusion, respectively.
In subsequent series of experiments, heart I was treated
with an intracoronary infusion of either free radical scavengers
(catalase and superoxide dismutase, 100 U/ml, n 5 4) or a
nitric oxide synthase inhibitor (N-omega-nitro-L-arginine,
100 mmol/liter, n 5 5). The infusion was started 20 min
before ischemia and was continued until the end of the
experiment. Furthermore, in four experiments, the second
heart was pretreated with an adenosine A1 (1,3-dipropyl-8-
cyclopentylxanthine [DPCPX], 1 mmol/liter) and A2 (3,7-
dimethyl-1-propargylxanthine [DMPX], 1 mmol/liter) receptor
antagonist over a period 20 min before and during sequential
perfusion.
Transmission electron microscopy. In separate experi-
ments, three hearts of each group were perfusion-fixed at the
end of the experiments. The fixative contained 0.1 mol/liter of
phosphate buffer and 2.5% glutaraldehyde at pH 7.3. Sections
of 1 mm3 were cut from the hearts and stored in 0.1 mol/liter
of phosphate buffer at pH 7.3 at 4°C. Samples were postfixed
with osmium tetroxide and dehydrated in an ascending series
of ethanol and embedded in epoxy resin. Sections of 1 mm
thickness, stained with toluidine blue, were examined before
sections for electron microscopy were cut. Ultrathin sections,
stained with uranyl acetate and lead citrate, were examined
and photographed with Zeiss EM 900 operated at 80 kV.
Drugs. Triton X-100 was obtained from Ferax (Berlin,
Germany) and GTN from Schwarz Pharma (Monheim, Ger-
many). Isoproterenol, papaverine, bradykinin, 5-HT, catalase,
superoxide dismutase and N-omega-nitro-L-arginine were ob-
tained from Sigma Chemical (Deisenhofen, Germany), and
DPCPX and DMPX from Research Biochemicals International.
Statistical analysis. Results are expressed as mean value 6
SEM for number of determinations. Nonparametric repeated
measures analysis of variance with data alignment was per-
formed for comparison of certain groups of interest. After
global testing, a multiple comparison procedure using the
Bonferroni-Holm adjustment of alpha was carried out.
Results
Effect of Triton X-100 on the contractile function of isolated
buffer perfused rat hearts. Before Triton X-100 treatment, all
contractile variables were stable at baseline (LVP 66 6
6 mm Hg, LVdP/dtmax 3,093 6 413 mm Hg/s and LVdP/dtmin
21,491 6 208 mm Hg/s). These variables significantly de-
creased during Triton X-100 treatment and then completely
recovered within 10 min. Coronary perfusion pressure mark-
edly increased and stabilized at a new baseline of 120 6 11 cm
H2O before serial perfusion. The effect of an intracoronary
infusion of isoproterenol (5 nmol/liter) before and after Triton
X-100 infusion is shown in Figure 3. Isoproterenol before the
endothelial damage induced an increase of LVP by 22% and of
LVdP/dtmax by 36%. After Triton X-100 treatment, the re-
sponse of these contractile variables to isoproterenol infusion
was only slightly reduced (LVP increased by 18% and LVdP/
dtmax increased by 28%). This indicates that the contractile
apparatus was still intact and the sarcolemmal beta-receptors
Figure 2. Experimental protocol. In the control group, sequential
perfusion was performed without preceding ischemia of heart I. In
groups I to III, serial perfusion was started after 10-min global
ischemia of heart I.
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as well as the beta-receptor signal transduction to the contrac-
tile apparatus was not significantly influenced by Triton X-100.
Effects of endothelial-dependent and -independent vasodi-
lators on rat coronary vasculature before and after Triton
X-100 infusion (Fig. 4). Before Triton X-100, the infusion of
all vasodilators induced rapid and pronounced coronary vaso-
dilation. After Triton X-100, the endothelial-dependent vaso-
dilators bradykinin and 5-HT caused a pronounced vasocon-
striction, suggesting that the coronary endothelium is severely
damaged and dysfunctional. In contrast, the vasodilative effect
of the endothelial-independent vasodilators GTN and papav-
erine was not modulated by Triton X-100, suggesting that the
smooth muscle cells were still intact (Fig. 4).
Ultrastructural damage in rat hearts produced by Triton
X-100. Figures 5 and 6 illustrate representative capillaries
from a control heart and a Triton X-100–treated heart. The
control capillary reveals an intact smooth endothelial cell and
normal appearance of cellular organelles and membranes. The
capillary from the treated heart shows destruction in the
endothelial monolayer with characteristic multiple perfora-
tions in the endothelial cell, pinocytotic vesicles within the
endothelial cell and surrounding tissue, some distortion of the
endothelial cell, as well as separation of the capillary from
surrounding tissue. The damage includes loss of cell cytoplasm
and severe disruption of the endothelial cell junctions, whereas
cell junctions from the control capillaries have a normal
overlapping appearance. Subjacent myocytes as well as smooth
muscle cells were undamaged by this treatment.
Hemodynamic changes observed in the second heart during
serial perfusion. In the control group (n 5 9), the LVP (75 6
4 mm Hg), LVdP/dtmax (2,805 6 152 mm Hg/s), LVdP/dtmin
(21,447 6 100 mm Hg/s), coronary perfusion pressure (78 6
2 cm H2O) and heart rate (281 6 13 beats/min) of heart II
were similar at baseline to the corresponding variables of heart
I. No relevant changes of these variables were observed during
serial perfusion under control conditions (Fig. 7). In contrast,
in group I (n 5 7), after 10 min of global ischemia of heart I,
the LVP (basal 77 6 6 mm Hg) of heart II immediately
decreased by 55%, LVdP/dtmax (basal 2,790 6 257 mm Hg/s)
by 66% and LVdP/dtmin (21,667 6 90 mm Hg/s) by 70% when
reperfusion was initiated. These variables increased again to
baseline levels within 10 min. Heart rate and coronary perfu-
sion pressure did not change significantly. After creating
Figure 4. Effect of Triton X-100 on the coronary flow changes induced
by endothelium-independent vasodilators (glyceryl trinitrate [GTN]
and papaverine [PAP]) and endothelium-dependent vasodilators (5-
hydroxytryptamine [5-HT] and bradykinin [BK]) in the isolated heart.
Data are presented as mean value 6 SEM.
Figure 5. Transmission electron micrographs of capillaries from a
control heart (top) showing an intact endothelial cell (EC), myocytes
(MC) and mitochondria (M) (bar 5 2 mm) and from a Triton
X-100–treated heart (bottom) showing a distorted endothelial cell,
characteristic multiple perforations in the endothelial cell and in-
creased fluid leakage around the capillary (asterisk) (bar 5 2 mm).
Figure 3. Effect of Triton X-100 on the isoproterenol (5 nmol/liter)-
induced increase of the contractile variables in the isolated heart. Data
are presented as mean value 6 SEM.
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selective endothelial damage to the first heart before global
ischemia in groups II (n 5 6) and III (n 5 6), the decrease of
the contractile variables at the onset of serial perfusion in heart
II was not significantly different compared with that in group I.
However, in group II, in contrast to the other groups, LVP and
LVdP/dt did not recover completely, and reached a new
plateau of 20% below baseline before ischemia. Furthermore,
in this group there was also a slight but significant decrease in
coronary perfusion pressure during the early phase of sequen-
tial perfusion. The negative inotropic effect was modulated by
neither pretreatment of heart I with N-omega-nitro-L-arginine
nor an infusion of free radical scavengers (superoxide dis-
mutase and catalase). Furthermore, the adenosine receptor
antagonists, infused either alone or in combination into heart
II, did not significantly influence the contractile response of
heart II at the onset of serial perfusion after a 10-min global
ischemia of heart I. Therefore, neither adenosine, nitric oxide
nor free radicals play a major role in the observed decrease in
contractility in heart II.
Discussion
The data presented show that, independent of the effect of
blood cells, a release of mediators from myocardial tissue may
contribute to contractile dysfunction after ischemia. Using a
Figure 6. Transmission electron micrographs of endothelial cell junc-
tions: control hearts (top) have cell junctions with a normal overlap-
ping appearance (bar 5 0.1 mm), whereas after endothelial damage
with Triton X-100 (bottom), a widened junction is shown (bar 5
0.1 mm). In addition, increased pinocytotic vesicles are shown in the
Triton X-100–treated hearts.
Figure 7. Changes in left ventricular contractile variables in heart II
exposed to sequential perfusion without preceding ischemia of heart I
(control group) and after a 10-min global ischemia of heart I (groups I to
III). In groups II and III the coronary endothelium of heart I was
damaged by Triton X-100 pretreatment and hyperkalemic infusion,
respectively. A, Left ventricular dP/dtmax (LVdP/dtmax). B, Left ventricular
dP/dtmin (LVdP/dtmin). Significant global differences were demonstrated
with respect to the effects between the groups. Moreover, multiple testing
of the same effect resulted in significant differences between the control
hearts and the remaining groups. The comparisons in the following mode
did not yield significant differences:
Effect: Between
Groups
LVdP/
dtmax
LVdP/
dtmin
Significance
Levels
Global testing 0.0004 0.0022 alpha 5 0.05
Multiple comparisons
Control–group II 0.0015 0.0032 alpha/6 5 0.0083
Control–group I 0.0026 0.0036 alpha/5 5 0.0100
Control–group III 0.0032 0.0095 alpha/4 5 0.0125
Significant results were also found for changes within subjects (time) and for
interactions (groups 3 time) with p , 0.001 in all comparisons (global and
multiple adjusted).
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model of sequential perfusion of two isolated hearts, the effects
of cardiodepressive agents released after global ischemia dur-
ing reperfusion of an isolated heart on a sequentially perfused
nonischemic second heart were characterized. During serial
perfusion, no relevant changes were observed in the left
ventricular contractile variables of the second heart under
control conditions. In contrast, when serial perfusion was
started after a 10-min global ischemia of the first heart, a
marked but reversible decrease in contractility was observed in
the second heart despite normoxia. Accordingly, electron
microscopy did not show any morphologic changes in the
second heart, which suggested that these changes are not due
to cellular damage.
Role of endothelial cells. Particular interest was focused on
the endothelial cell layer as a potential source of the media-
tors. The role of the endothelium in the regulation of vascular
smooth muscle tone is well established. Furthermore, recent
studies suggest that the endothelial cell lining may also influ-
ence myocardial contractility (7–10,12–14). The possible un-
derlying mechanisms are modulation of myofilament calcium
responsiveness or affinitiy (18,30,31) and release of an upregu-
lating and downregulating factor involving a cyclic adenosine
monophosphate–sensitive mechanism for regulating the con-
tractile proteins (32,33).
At present, there are few data available on the potential
role of endothelial cells with regard to myocardial contractility
after ischemia. By creating severe vascular endothelial damage
to the first heart by Triton X-100 or hyperkalemic infusion
before global ischemia, the role of endothelial cells as a
putative source of the mediator(s) was investigated in the
double-heart model. The cardiodepressive effect observed
after global ischemia of the first heart at the onset of serial
perfusion in the second heart did not depend on functional or
morphologic integrity of the vascular endothelial cells. There-
fore, the negative inotropic mediators released after global
ischemia during reperfusion obviously did not originate from
coronary endothelial cells.
Furthermore, despite creating endothelial damage to either
the second heart or to both hearts, the observed negative
inotropic effect in the second heart was not modified. This
suggests that the endothelial cell lining does not play a role as
a physiologic barrier or have a transmitter role in response to
the cardiodepressive mediator released by the first heart in this
experimental setup.
Chemical structure of the cardiodepressive mediator.
Until now, we have not identified the chemical structure of the
mediator(s). Among the known negative inotropic agents
released from endothelial cells after ischemia, free radicals,
adenosine or nitric oxide may be involved. However, it is
unlikely that these mediators would play a role in mediating
the cardiodepressive effect described here, because adminis-
tration of free radical scavengers, adenosine alpha1 and alpha2
receptor antagonists and a nitric oxide synthase inhibitor did
not influence the hemodynamic changes observed in the
second heart at the onset of serial perfusion. Finally, by means
of serial analysis and equilibration of pH, partial pressure of
oxygen and electrolytes of the coronary effluent of the first
heart before sequential perfusion, we were able to exclude the
possibility that the hemodynamic changes are caused by ionic
changes, acidosis or hypoxia in the coronary effluent of the first
heart.
Conclusions. Our data demonstrate that cardiodepressive
mediators are released after ischemia during reperfusion.
These negative inotropic mediators are not derived from
coronary endothelial cell metabolism, because severe selective
endothelial damage of the first heart before ischemia does not
modulate the observed cardiodepressive effect. As mentioned
earlier, known mediators that are released after ischemia and
that display negative inotropic effects (i.e., nitric oxide, aden-
osine and oxygen free radicals) are not involved. Even so, no
direct evidence that identifies the structure of these mediators
has become available until now. Further studies are necessary
to characterize the chemical structure as well as the cellular
source of these mediators.
We thank Marcus Drechsler, PhD for assistance in preparation of the micro-
graphs.
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